Scholars Central

Research articlePublished 2010

Bioequivalence Testing - Industry Perspective

Authors: Akula Thukaram Bapuji, Hamsa Lakshmi Venkata Ravikiran, Meda Nagesh, Syed Syedba, Datla Ramaraju, Chinnapu Reddy Jayaprakash Reddy, Sreedasyam Ravinder, Rosi Reddy Yeruva, Sutirtha Roy

Journal of Bioequivalence & Bioavailability

Volume 2 · Issue 5 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Generic drugs are cost effective alternatives for the brand name drugs and the savings are estimated in the average $8 to $10 billion a year. Over the years the prescription of generic drugs has increased from 19% to 60-70% (1984: 19% & 2009- 60-70%). Bioequivalence testing is playing a vital role in generic drug development. But to make a generic drug enter in to a regulated market a company has to meet the stringent criteria in the same way as innovative drugs. But the criterion’s set forth by the regulatories are not always very descriptive and entrepreneur friendly. The prevailing fi erce competition also makes the manufacturers to keep low prices. In order to keep the tight price schedule for generic drugs one must have a clear picture on bioequivalence studies from industry perspective. There are some issues constantly faced by the industry for proper conduct of the BA/BE studies. The review article describes current regulatory requirements from various regulatory agencies and its impact on industry while designing a bioequivalence study and also highlights some of the common areas, which need to be addressed or commented upon. It is the time for industry to partner with regulatories to make bioequivalence studies and intern development of generic drugs more cost effective.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Akula Thukaram Bapuji”
  • BylineArticles whose byline prints “Hamsa Lakshmi Venkata Ravikiran”
  • BylineArticles whose byline prints “Meda Nagesh”
  • BylineArticles whose byline prints “Syed Syedba”
  • BylineArticles whose byline prints “Datla Ramaraju”
  • BylineArticles whose byline prints “Chinnapu Reddy Jayaprakash Reddy”
  • BylineArticles whose byline prints “Sreedasyam Ravinder”
  • BylineArticles whose byline prints “Rosi Reddy Yeruva”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels